Alexion Pharmaceuticals, Inc.
Treating seizure with recombinant alkaline phosphatase

Abstract:

The present disclosure provides a method of treating seizure in a subject having aberrant alkaline phosphatase activities, comprising administering a therapeutically effective amount of at least one recombinant alkaline phosphatase to the subject.